U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07147972) titled 'Comparative Study of Nutraceuticals vs. Conventional Prophylactic Therapy in the Management of Migraine' on Aug. 16.
Brief Summary: Migraine is a common disabling neurological condition that significantly affects quality of life. While traditional prophylactic treatments (e.g., beta-blockers, antiepileptics) are effective, they may be associated with side effects leading to poor adherence. Recent evidence suggests that nutraceuticals like magnesium, riboflavin, and coenzyme Q10 may provide a safer alternative. This study aims to compare the efficacy and tolerability of these two approaches.
Study Start Date: Aug. 20
Study Type: IN...